Σεπ162015Βιβλιογραφικά δεδομέναΓια να δείτε το άρθρο πιέστε εδώ Κατηγορία Βιβλιογραφικά δεδομένα16 Σεπτεμβρίου 2015 Μοιραστείτε το! Share on FacebookShare on Facebook Share on XShare on X Share on LinkedInShare on LinkedIn Share on WhatsAppShare on WhatsApp Post navigationΠροηγούμενοPrevious post:Long-term safety of oral nucleos(t)ide analogs for patients with chronic hepatitis B: A cohort study of 53,500 subjects.ΕπόμενοNext post:Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses.Σχετικά ΆρθραAutoimmune liver diseases in Latin America: Current landscape and challenge29 Ιανουαρίου 2026Cardiovascular-kidney-metabolic (CKM) syndrome is associated with increased mortality in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD)27 Ιανουαρίου 2026The 2024 diagnostic criteria for primary sclerosing cholangitis26 Ιανουαρίου 2026Impact of first and further decompensation in patients with compensated ACLD due to MASLD23 Ιανουαρίου 2026Anti-HBs immune complex levels: A novel marker of hepatitis flare following nucleos(t)ide analogue withdrawal in HBeAg-negative chronic hepatitis B21 Ιανουαρίου 2026Establishing hepatic decompensation as a meaningful clinical outcome during systemic therapy for hepatocellular carcinoma19 Ιανουαρίου 2026
Cardiovascular-kidney-metabolic (CKM) syndrome is associated with increased mortality in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD)27 Ιανουαρίου 2026
Impact of first and further decompensation in patients with compensated ACLD due to MASLD23 Ιανουαρίου 2026
Anti-HBs immune complex levels: A novel marker of hepatitis flare following nucleos(t)ide analogue withdrawal in HBeAg-negative chronic hepatitis B21 Ιανουαρίου 2026
Establishing hepatic decompensation as a meaningful clinical outcome during systemic therapy for hepatocellular carcinoma19 Ιανουαρίου 2026
